Investing Profile

Kazumi Shiosaki

VC

Photo of Kazumi Shiosaki, Managing Partner at MPM Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
UC Berkeley Network
27 CONNECTIONS
cb
MPM Capital Managing Partner
2
$52.7M
CompanyStageDateRound SizeTotal Raised
Twentyeight-Seven Therapeutics
Series ASep 2018$65M
$65M
Co-investors: Luke Evnin (MPM Capital)
Epizyme
Series BOct 2009$32M
$40M
Co-investors: Beth Seidenberg (Kleiner Perkins), David Mott (Mott Family Capital)
Managing Director MPM CapitalPresent
CEO Epizyme2007 - 2010
CEO Primera2004 - 2006
SVP Drug Discovery Millennium Pharmaceuticals1997 - 2001
UC Berkeley PhD Synthetic Chemistry